Staphylococcal secretory inhibitor of platelet microbicidal protein is associated with prostatitis source Free

Abstract

This study reports the detection of an extracellular staphylococcal product, designated secretory inhibitor of platelet microbicidal protein (SIPMP), that causes local inhibition of the bactericidal action of platelet microbicidal protein (PMP) in the fluid phase. Urethral isolates of (=24) and coagulase-negative staphylococci (CNS) (=47) from patients with or without chronic bacterial prostatitis (CBP) were tested. SIPMP production was tested by inhibition of PMP bioactivity against and was expressed as percentage inhibition of PMP bactericidal activity. The PMP susceptibility of staphylococcal strains was determined by exposing bacterial cells to serial dilutions of PMP. Staphylococci from patients without CBP produced SIPMP at levels of 10.3±1.2 and 13.25±1.72 % for and CNS, respectively. Strains isolated from men with CBP inhibited PMP-induced killing of by 23.38±4.2 % (<0.05) and 23.69±1.87 % (<0.01) for and CNS, respectively. SIPMP production correlated with staphylococcal resistance to PMP ( =0.6082 and 0.7264 for and CNS, respectively). SIPMP represents a hitherto unrecognized determinant of staphylococcal pathogenicity. These results suggest that SIPMP production is associated with the CBP source. Data from this study may have significant implications for the understanding of the pathogenesis of CBP.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46752-0
2006-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1645.html?itemId=/content/journal/jmm/10.1099/jmm.0.46752-0&mimeType=html&fmt=ahah

References

  1. Bukharin O. V., Brudastov I. A., Gritsenko V. A., Deriabin D. G. 1996; Role of the ability of bacteria to inactivate natural anti-infective resistance factors in their resistance to blood bactericidal action (blood serum). Biull Eksp Biol Med 121:174–176 [CrossRef]
    [Google Scholar]
  2. Com E., Bourgeon F., Evrard B., Ganz T., Colleu D., Jégou B., Pineau C. 2003; Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol Reprod 68:95–104
    [Google Scholar]
  3. Dankert J. 1988; Role of platelets in early pathogenesis of viridans group streptococcal endocarditis: a study on thrombodefensins . PhD thesis University of Groningen; Groningen, The Netherlands:
  4. Dankert J., van der Werff J., Zaat S. A. J., Joldersma W., Klein D., Hess J. 1995; Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 63:663–671
    [Google Scholar]
  5. Deckers D., Masschalck B., Aertsen A., Callewaert I., van Tiggelen C. G. M., Atanassova M., Michiels C. W. 2004; Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli . Cell Mol Life Sci 61:1229–1237 [CrossRef]
    [Google Scholar]
  6. Dhawan V. K., Yeaman M. R., Cheung A. L., Kim E., Sullam P. M., Bayer A. S. 1997; Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus . Infect Immun 65:3293–3299
    [Google Scholar]
  7. Domingue G. J. Sr., Hellstrom W. J. G. 1998; Prostatitis. Clin Microbiol Rev 11:604–613
    [Google Scholar]
  8. Donaldson D. M., Tew J. G. 1977; β -Lysin of platelet origin. Bacteriol Rev 41:501–513
    [Google Scholar]
  9. Dürr M., Peschel A. 2002; Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 70:6515–6517 [CrossRef]
    [Google Scholar]
  10. Everaert K., Mahmoud A., Depuydt C., Maeyaert M., Comhaire F. 2003; Chronic prostatitis and male accessory gland infection – is there an impact on male infertility (diagnosis and therapy)?. Andrologia 35:325–330 [CrossRef]
    [Google Scholar]
  11. Fair W. R., Parrish R. F. 1981; Antibacterial substances in prostatic fluid. Prog Clin Biol Res 75A:247–264
    [Google Scholar]
  12. Fernie-King B. A., Seilly D. J., Davies A., Lachmann P. J. 2002; Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 70:4908–4916 [CrossRef]
    [Google Scholar]
  13. Hancock R. E. W., Chapple D. S. 1999; Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323
    [Google Scholar]
  14. Hirsch J. G. 1960; Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 112:15–22 [CrossRef]
    [Google Scholar]
  15. Hoe N. P., Vuopio-Varkila J., Vaara M. & 7 other authors; 2001; Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 183:633–639 [CrossRef]
    [Google Scholar]
  16. Hua V. N., Williams D. H., Schaeffer A. J. 2005; Role of bacteria in chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 6:300–306 [CrossRef]
    [Google Scholar]
  17. Ivanov I. B. 2005; I n vitro resistance to human platelet microbicidal protein among urethral staphylococcal and enterococcal isolates with its correlation with prostatitis. Indian J Med Microbiol 23:253–255
    [Google Scholar]
  18. Krijgsveld J., Zaat S. A. J., Meeldijk J. & 9 other authors; 2000; Thrombocidins, microbicidal proteins from human platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374–20381 [CrossRef]
    [Google Scholar]
  19. Kupferwasser L. I., Skurray R. A., Brown M. H., Firth N., Yeaman M. R., Bayer A. S. 1999; Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob Agents Chemother 43:2395–2399
    [Google Scholar]
  20. Kupferwasser L. I., Yeaman M. R., Shapiro S. M., Nast C. C., Bayer A. S. 2002; In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105:746–752 [CrossRef]
    [Google Scholar]
  21. Langley R., Wines B., Willoughby N., Basu I., Proft T., Fraser J. D. 2005; The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc α RI and serum killing of bacteria. J Immunol 174:2926–2933 [CrossRef]
    [Google Scholar]
  22. Lowentritt J. E., Kawahara K., Human L. G., Hellstrom W. J. G., Domingue G. J. 1995; Bacterial infection in prostatodynia. J Urol 154:1378–1381 [CrossRef]
    [Google Scholar]
  23. Schoor R. A. 2002; Prostatitis and male infertility: evidence and links. Curr Urol Rep 3:324–329 [CrossRef]
    [Google Scholar]
  24. Terai A., Ishitoya S., Mitsumori K., Ogawa O. 2000; Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J Urol 164:1945–1947 [CrossRef]
    [Google Scholar]
  25. Wu T., Yeaman M. R., Bayer A. S. 1994; In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 38:729–732 [CrossRef]
    [Google Scholar]
  26. Yeaman M. R. 1997; The role of platelets in antimicrobial host defense. Clin Infect Dis 25:951–968 [CrossRef]
    [Google Scholar]
  27. Yeaman M. R., Puentes S. M., Norman D. C., Bayer A. S. 1992; Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 60:1202–1209
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46752-0
Loading
/content/journal/jmm/10.1099/jmm.0.46752-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed